APOA1 CRISPR Knockout HepG2
To Order Contact us: bjorn@lembcke.dk
Mouse Apolipoprotein A1 (APOA1) ELISA Kit |
|||
| DLR-APOA1-Mu-48T | DL Develop | 48T | EUR 540 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Apolipoprotein A1 (APOA1) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
|||
Mouse Apolipoprotein A1 (APOA1) ELISA Kit |
|||
| DLR-APOA1-Mu-96T | DL Develop | 96T | EUR 698.4 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Mouse Apolipoprotein A1 (APOA1) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
|||
Porcine Apolipoprotein A1 (APOA1) ELISA Kit |
|||
| DLR-APOA1-p-48T | DL Develop | 48T | EUR 656.4 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Porcine Apolipoprotein A1 (APOA1) in samples from serum, plasma or other biological fluids. |
|||
Porcine Apolipoprotein A1 (APOA1) ELISA Kit |
|||
| DLR-APOA1-p-96T | DL Develop | 96T | EUR 858 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Porcine Apolipoprotein A1 (APOA1) in samples from serum, plasma or other biological fluids. |
|||
Rat Apolipoprotein A1 (APOA1) ELISA Kit |
|||
| DLR-APOA1-Ra-48T | DL Develop | 48T | EUR 560.4 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Rat Apolipoprotein A1 (APOA1) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
|||
Rat Apolipoprotein A1 (APOA1) ELISA Kit |
|||
| DLR-APOA1-Ra-96T | DL Develop | 96T | EUR 726 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Rat Apolipoprotein A1 (APOA1) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
|||
Rabbit Apolipoprotein A1 (APOA1) ELISA Kit |
|||
| DLR-APOA1-Rb-48T | DL Develop | 48T | EUR 560.4 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Rabbit Apolipoprotein A1 (APOA1) in samples from serum, plasma or other biological fluids. |
|||
Rabbit Apolipoprotein A1 (APOA1) ELISA Kit |
|||
| DLR-APOA1-Rb-96T | DL Develop | 96T | EUR 726 |
|
Description: A competitive inhibition quantitative ELISA assay kit for detection of Rabbit Apolipoprotein A1 (APOA1) in samples from serum, plasma or other biological fluids. |
|||
Monkey Apolipoprotein A1 (APOA1) ELISA Kit |
|||
| DLR-APOA1-Si-48T | DL Develop | 48T | EUR 691.2 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Monkey Apolipoprotein A1 (APOA1) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
|||
Monkey Apolipoprotein A1 (APOA1) ELISA Kit |
|||
| DLR-APOA1-Si-96T | DL Develop | 96T | EUR 906 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Monkey Apolipoprotein A1 (APOA1) in samples from serum, plasma, tissue homogenates, cell lysates, cell culture supernates or other biological fluids. |
|||
Human Apolipoprotein A1 (APOA1) ELISA Kit |
|||
| RDR-APOA1-Hu-48Tests | Reddot Biotech | 48 Tests | EUR 546 |
Human Apolipoprotein A1 (APOA1) ELISA Kit |
|||
| RDR-APOA1-Hu-96Tests | Reddot Biotech | 96 Tests | EUR 754.8 |
Mouse Apolipoprotein A1 (APOA1) ELISA Kit |
|||
| RDR-APOA1-Mu-48Tests | Reddot Biotech | 48 Tests | EUR 558 |
Mouse Apolipoprotein A1 (APOA1) ELISA Kit |
|||
| RDR-APOA1-Mu-96Tests | Reddot Biotech | 96 Tests | EUR 771.6 |
Porcine Apolipoprotein A1 (APOA1) ELISA Kit |
|||
| RDR-APOA1-p-48Tests | Reddot Biotech | 48 Tests | EUR 696 |
Porcine Apolipoprotein A1 (APOA1) ELISA Kit |
|||
| RDR-APOA1-p-96Tests | Reddot Biotech | 96 Tests | EUR 968.4 |
Rat Apolipoprotein A1 (APOA1) ELISA Kit |
|||
| RDR-APOA1-Ra-48Tests | Reddot Biotech | 48 Tests | EUR 583.2 |
Rat Apolipoprotein A1 (APOA1) ELISA Kit |
|||
| RDR-APOA1-Ra-96Tests | Reddot Biotech | 96 Tests | EUR 806.4 |
Rabbit Apolipoprotein A1 (APOA1) ELISA Kit |
|||
| RDR-APOA1-Rb-48Tests | Reddot Biotech | 48 Tests | EUR 583.2 |
Rabbit Apolipoprotein A1 (APOA1) ELISA Kit |
|||
| RDR-APOA1-Rb-96Tests | Reddot Biotech | 96 Tests | EUR 806.4 |
Monkey Apolipoprotein A1 (APOA1) ELISA Kit |
|||
| RDR-APOA1-Si-48Tests | Reddot Biotech | 48 Tests | EUR 736.8 |
Monkey Apolipoprotein A1 (APOA1) ELISA Kit |
|||
| RDR-APOA1-Si-96Tests | Reddot Biotech | 96 Tests | EUR 1027.2 |
Human Apolipoprotein A1 (APOA1) ELISA Kit |
|||
| RD-APOA1-Hu-48Tests | Reddot Biotech | 48 Tests | EUR 523.2 |
Human Apolipoprotein A1 (APOA1) ELISA Kit |
|||
| RD-APOA1-Hu-96Tests | Reddot Biotech | 96 Tests | EUR 721.2 |
Mouse Apolipoprotein A1 (APOA1) ELISA Kit |
|||
| RD-APOA1-Mu-48Tests | Reddot Biotech | 48 Tests | EUR 535.2 |
Mouse Apolipoprotein A1 (APOA1) ELISA Kit |
|||
| RD-APOA1-Mu-96Tests | Reddot Biotech | 96 Tests | EUR 738 |
Porcine Apolipoprotein A1 (APOA1) ELISA Kit |
|||
| RD-APOA1-p-48Tests | Reddot Biotech | 48 Tests | EUR 666 |
Porcine Apolipoprotein A1 (APOA1) ELISA Kit |
|||
| RD-APOA1-p-96Tests | Reddot Biotech | 96 Tests | EUR 925.2 |
Rat Apolipoprotein A1 (APOA1) ELISA Kit |
|||
| RD-APOA1-Ra-48Tests | Reddot Biotech | 48 Tests | EUR 558 |
Rat Apolipoprotein A1 (APOA1) ELISA Kit |
|||
| RD-APOA1-Ra-96Tests | Reddot Biotech | 96 Tests | EUR 771.6 |
Rabbit Apolipoprotein A1 (APOA1) ELISA Kit |
|||
| RD-APOA1-Rb-48Tests | Reddot Biotech | 48 Tests | EUR 558 |
Rabbit Apolipoprotein A1 (APOA1) ELISA Kit |
|||
| RD-APOA1-Rb-96Tests | Reddot Biotech | 96 Tests | EUR 771.6 |
Monkey Apolipoprotein A1 (APOA1) ELISA Kit |
|||
| RD-APOA1-Si-48Tests | Reddot Biotech | 48 Tests | EUR 704.4 |
Monkey Apolipoprotein A1 (APOA1) ELISA Kit |
|||
| RD-APOA1-Si-96Tests | Reddot Biotech | 96 Tests | EUR 981.6 |
B2M Knockout Jurkat Cell Line |
|||
| 78342 | BPS Bioscience | 2 vials | EUR 6500 |
|
Description: B2M (Beta-2-Microglobulin) has been genetically removed by CRISPR/Cas9 genome editing from Jurkat cells. |
|||
TCR Knockout Jurkat Cell Line |
|||
| 78539 | BPS Bioscience | 2 vials | EUR 6500 |
|
Description: The TCR Knockout Jurkat cell line was generated by CRISPR/Cas9 genome editing to remove the TRAC (T-Cell Receptor Alpha Constant) and TRBC1 (T-Cell Receptor Beta Constant 1) domains of the TCRα and β chains. |
|||
CRISPR/Cas9 Kinase Knockout Lentivirus Library (Array Format) |
|||
| 78487 | BPS Bioscience | 200 µl x 649 | EUR 7700 |
|
Description: The CRISPR/Cas9 Kinase Knockout Lentivirus Library (Array Format) targets 619 human kinases and pseudo-kinases.bpsbioscience.com/media/wysiwyg/Kinases/Kinase_Library_-_List_Kinases_Pseudokinases_06-15-2022.xlsx Download the table to view all available kinases. The Array consists of a series of vials, with each vial containing a mixture of integrating CRISPR/Cas9 lentiviral particles targeting 5 sgRNAs for a specific gene (1 vial per gene, 5 sgRNAs per gene). The Array also includes a total of 150 control sgRNAs that do not target any gene (combined into 30 vials containing 5 control sgRNAs per vial). Thus, the Array contains a total of 649 vials and 3,245 sgRNAs.The lentiviruses are replication incompetent, VSV-G pseudotyped lentiviral particles ready to infect almost all types of mammalian cells, including primary and non-dividing cells. The SIN (self-inactivation) lentiviral backbone contains the Cas9 gene (Streptococcus pyogenes CRISPR associated protein 9) driven by an EF1a promoter, an sgRNA driven by a U6 promoter, and a puromycin selection marker.The lentiviruses integrate randomly into the cellular genome to express both Cas9 and the sgRNAs. Because the lentiviruses contain Cas9, they can be used in any target cell regardless of whether the cells already express Cas9. Puromycin selection ensures high expression of both Cas9 and the sgRNAs. Knockout efficiencies will depend on the cell type and the gene of interest. Stable CRISPR/Cas9 knockout cell lines can also be generated following limiting dilution.The library is delivered with a User Manual booklet. |
|||
Human HepG2 Whole Cell Lysate |
|||
| LYSATE0029 | BosterBio | 200ug | EUR 180 |
|
Description: This cell lysate is prepared from human HepG2 using Boster's RIPA Lysis Buffer (AR0105) using a standard whole cell lysate protocol. The concentration was determined using the BCA assay process and then diluted using Dithiothreitol (DTT) and a reducing SDS sample loading buffer, heated for 5 minutes at 100˚C. |
|||
Human HepG2 (Hepatocellular Carcinoma) lysate |
|||
| HCL-1211 | Alpha Diagnostics | 100ug | EUR 285.6 |
pGreenFire1- PPRE (HepG2 cell line) |
|||
| TR101A-P | SBI | >2 x 10^6 cells | EUR 3915.6 |
CRISPRa (SAM) HepG2 Cell Line |
|||
| 78194 | BPS Bioscience | 2 vials | EUR 2500 |
|
Description: This cell line has been engineered for use with the CRISPR Synergistic Activation Mediator (SAM) system to induce transcriptional activation and expression of any gene of interest. Cells stably express a mutated dCas9 (Streptococcus pyogenes CRISPR associated protein 9), lacking any endonuclease activity, fused to VP64, a transcriptional activator. Stable dCas9-VP64 expression is maintained with Blasticidin resistance. Cells also stably express P65 (Transcription Factor p65, or Nuclear Factor NF-κB p65) and HSF1 (Heat Shock Factor 1) fused with an MS2 tag, which is maintained with Hygromycin resistance. When these cells are transfected with an MS2- tagged sgRNA targeting the promoter region of the gene of interest, dCas9-VP64 and MS2-P65-HSF1 are recruited to the site in the genomic DNA and begin transcription, inducing expression of the desired gene. |
|||
B2M Knockout THP-1 Cell Line |
|||
| 78389 | BPS Bioscience | 2 vials | EUR 6500 |
|
Description: B2M (Beta-2-Microglobulin) has been genetically removed by CRISPR/Cas9 genome editing from THP-1 cells. |
|||
CIITA Knockout THP-1 Cell Line |
|||
| 78390 | BPS Bioscience | 2 vials | EUR 6500 |
|
Description: CIITA (Class II Transactivator) has been genetically removed from THP-1 cells using CRISPR/Cas9 genome editing. |
|||
FCGR2A (CD32A) Knockout Jurkat Cell Line |
|||
| 78549 | BPS Bioscience | 2 vials | EUR 6500 |
|
Description: The FCGR2A Knockout Jurkat cell line was generated by CRISPR/Cas9 genome editing to remove FCGR2A (CD32A), the gene encoding protein FcγRIIa (Fragment crystallizable gamma receptor II a, also known as FcGRIIa, Fc-gamma-RIIa, and CD32A). |
|||
TCR/B2M Knockout Jurkat Cell Line |
|||
| 78552 | BPS Bioscience | 2 vials | EUR 8645 |
|
Description: This cell line is a double knockout of TCR (T Cell Receptor) and B2M (Beta-2-Microglobulin). First, the TRAC (T-Cell Receptor Alpha Constant) and the TRBC1 (T-Cell Receptor Beta Constant 1) domains of the TCRα/β chains were genetically removed by CRISPR/Cas9 genome editing from Jurkat cells to generate the TCR Knockout Jurkat cell Line (BPS Bioscience #78539). These TCR knockout cells were then used to generate a new cell line in which B2M was also genetically removed by CRISPR/Cas9 genome editing. |
|||
HEP G2 Whole Cell Lysate (Hepatoblastoma cells) |
|||
| HEPG2-100 | Alpha Diagnostics | 100 ug | EUR 196.8 |
HEP G2 Whole Cell Lysate (Hepatoblastoma cells) |
|||
| HEPG2-50 | Alpha Diagnostics | 50 ug | EUR 153.6 |
APOA1 Antibody |
|||
| 1-CSB-PA225650 | Cusabio |
|
|
|
Description: A polyclonal antibody against APOA1. Recognizes APOA1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:25-1:100 |
|||
APOA1 Antibody |
|||
| 1-CSB-PA001913GA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against APOA1. Recognizes APOA1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC |
|||
APOA1 Antibody |
|||
| 1-CSB-PA001913HA01HU | Cusabio |
|
|
|
Description: A polyclonal antibody against APOA1. Recognizes APOA1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA |
|||
APOA1 Antibody |
|||
| 1-CSB-PA001913LA01BO | Cusabio |
|
|
|
Description: A polyclonal antibody against APOA1. Recognizes APOA1 from Bovine, Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB; Recommended dilution: WB:1:1000-1:5000 |
|||
APOA1 Antibody |
|||
| DF6264 | Affbiotech | 200ul | EUR 420 |
APOA1 siRNA |
|||
| 20-abx907810 | Abbexa |
|
|
APOA1 siRNA |
|||
| 20-abx907811 | Abbexa |
|
|
APOA1 Antibody |
|||
| 1-CSB-PA005772 | Cusabio |
|
|
|
Description: A polyclonal antibody against APOA1. Recognizes APOA1 from Human, Mouse. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/20000 |
|||
APOA1 Antibody |
|||
| 1-CSB-PA551448 | Cusabio |
|
|
|
Description: A polyclonal antibody against APOA1. Recognizes APOA1 from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC;ELISA:1:2000-1:5000, IHC:1:25-1:100 |
|||
APOA1 Peptide |
|||
| 43-243P | ProSci | 0.1 mg | EUR 405.6 |
APOA1 Peptide |
|||
| 43-646P | ProSci | 0.1 mg | EUR 405.6 |
ApoA1 Antibody |
|||
| 5097-002mg | ProSci | 0.02 mg | EUR 206.18 |
|
Description: ApoA1 Antibody: Apolipoprotein A1 (ApoA1) is the major protein component of high density lipoprotein (HDL) in plasma. ApoA1 is synthesized in the liver and small intestine and promotes cholesterol efflux from tissues to the liver for excretion. It is a cofactor for lecithin cholesterolacyltransferase (LCAT), the enzyme responsible for the formation of most plasma cholesteryl esters. Defects in ApoA1 are associated with HDL deficiency, Tangier disease, and systemic non-neuropathic amyloidosis. |
|||
ApoA1 Antibody |
|||
| 5097-01mg | ProSci | 0.1 mg | EUR 523.7 |
|
Description: ApoA1 Antibody: Apolipoprotein A1 (ApoA1) is the major protein component of high density lipoprotein (HDL) in plasma. ApoA1 is synthesized in the liver and small intestine and promotes cholesterol efflux from tissues to the liver for excretion. It is a cofactor for lecithin cholesterolacyltransferase (LCAT), the enzyme responsible for the formation of most plasma cholesteryl esters. Defects in ApoA1 are associated with HDL deficiency, Tangier disease, and systemic non-neuropathic amyloidosis. |
|||
ApoA1 Peptide |
|||
| 5097P | ProSci | 0.05 mg | EUR 197.7 |
|
Description: (NT) ApoA1 peptide |
|||
ApoA1 antibody |
|||
| 70R-12417 | Fitzgerald | 100 ug | EUR 483.6 |
|
Description: Rabbit polyclonal ApoA1 antibody |
|||
ApoA1 antibody |
|||
| 70R-12418 | Fitzgerald | 100 ug | EUR 483.6 |
|
Description: Rabbit polyclonal ApoA1 antibody |
|||
ApoA1 Antibody |
|||
| 6265-002mg | ProSci | 0.02 mg | EUR 206.18 |
|
Description: ApoA1 Antibody: Apolipoprotein A1 (ApoA1) is the major protein component of high density lipoprotein (HDL) in plasma, which is correlated with cardiovascular disease. ApoA1 is synthesized in the liver and small intestine and promotes cholesterol efflux from tissues to the liver for excretion. It is a cofactor for lecithin cholesterolacyltransferase (LCAT), the enzyme responsible for the formation of most plasma cholesteryl esters. Defects in ApoA1 are associated with HDL deficiency, Tangier disease, and systemic non-neuropathic amyloidosis. |
|||
ApoA1 Antibody |
|||
| 6265-01mg | ProSci | 0.1 mg | EUR 523.7 |
|
Description: ApoA1 Antibody: Apolipoprotein A1 (ApoA1) is the major protein component of high density lipoprotein (HDL) in plasma, which is correlated with cardiovascular disease. ApoA1 is synthesized in the liver and small intestine and promotes cholesterol efflux from tissues to the liver for excretion. It is a cofactor for lecithin cholesterolacyltransferase (LCAT), the enzyme responsible for the formation of most plasma cholesteryl esters. Defects in ApoA1 are associated with HDL deficiency, Tangier disease, and systemic non-neuropathic amyloidosis. |
|||
ApoA1 Peptide |
|||
| 6265P | ProSci | 0.05 mg | EUR 197.7 |
|
Description: (CT) ApoA1 peptide |
|||
APOA1 antibody |
|||
| 70R-15769 | Fitzgerald | 50 ul | EUR 522 |
|
Description: Rabbit polyclonal APOA1 antibody |
|||
ApoA1 antibody |
|||
| 70R-13840 | Fitzgerald | 100 ug | EUR 386.4 |
|
Description: Affinity purified Rabbit polyclonal ApoA1 antibody |
|||
APOA1 antibody |
|||
| 38197-100ul | SAB | 100ul | EUR 302.4 |
ApoA1 protein |
|||
| 30R-2378 | Fitzgerald | 20 ug | EUR 177.6 |
|
Description: Purified recombinant Human ApoA1 protein |
|||
ApoA1 protein |
|||
| 30R-2379 | Fitzgerald | 20 ug | EUR 216 |
|
Description: Purified recombinant Rat ApoA1 protein |
|||
APOA1 Protein |
|||
| 30R-3414 | Fitzgerald | 1 mg | EUR 891.6 |
|
Description: Human Apolipoprotein A1 |
|||
ApoA1 Antibody |
|||
| 24862-100ul | SAB | 100ul | EUR 468 |
APOA1 Antibody |
|||
| 35570-100ul | SAB | 100ul | EUR 302.4 |
ApoA1 antibody |
|||
| 20R-1850 | Fitzgerald | 100 ug | EUR 807.6 |
|
Description: Rabbit polyclonal ApoA1 antibody |
|||
ApoA1 Antibody |
|||
| 25292-100ul | SAB | 100ul | EUR 468 |
ApoA1 antibody |
|||
| 10R-10374 | Fitzgerald | 100 ug | EUR 522 |
|
Description: Mouse monoclonal ApoA1 antibody |
|||
ApoA1 antibody |
|||
| 10R-10571 | Fitzgerald | 100 ug | EUR 418.8 |
|
Description: Mouse monoclonal ApoA1 antibody |
|||
ApoA1 protein |
|||
| 30-1047S | Fitzgerald | 100 ug | EUR 194.4 |
|
Description: Purified native Human ApoA1 protein |
|||
ApoA1 protein |
|||
| 30-1341 | Fitzgerald | 100 ug | EUR 390 |
|
Description: Purified native ApoA1 protein |
|||
APOA1 antibody |
|||
| 10R-3134 | Fitzgerald | 100 ul | EUR 418.8 |
|
Description: Mouse monoclonal APOA1 antibody |
|||
ApoA1 antibody |
|||
| 10-A10 | Fitzgerald | 1 mg | EUR 211.2 |
|
Description: Mouse monoclonal ApoA1 antibody |
|||
APOA1 Antibody |
|||
| ABD6264 | Lifescience Market | 100 ug | EUR 525.6 |
APOA1 Protein |
|||
| 20-abx262990 | Abbexa |
|
|
APOA1 Protein |
|||
| 20-abx263126 | Abbexa |
|
|
APOA1 siRNA |
|||
| 20-abx900370 | Abbexa |
|
|
APOA1 protein |
|||
| 80R-4196 | Fitzgerald | 100 ul | EUR 418.8 |
|
Description: Recombinant Mouse APOA1 protein with His tag |
|||
APOA1 Antibody |
|||
| BF0578 | Affbiotech | 200ul | EUR 540 |
APOA1 Antibody |
|||
| R35834-100UG | NSJ Bioreagents | 100 ug | EUR 399 |
APOA1 Antibody |
|||
| R33650-100UG | NSJ Bioreagents | 100 ug | EUR 399 |
ApoA1 Antibody |
|||
| 5693-100 | Biovision | each | EUR 379.2 |
ApoA1 Antibody |
|||
| 5693-30T | Biovision | each | EUR 175.2 |
ApoA1 Antibody |
|||
| 5695-100 | Biovision | each | EUR 379.2 |
ApoA1 Antibody |
|||
| 5695-30T | Biovision | each | EUR 175.2 |
APOA1 Antibody |
|||
| F50384-0.4ML | NSJ Bioreagents | 0.4 ml | EUR 379 |
B2M Knockout NFAT Luciferase Reporter Jurkat Cell Line |
|||
| 78363 | BPS Bioscience | 2 vials | EUR 11095 |
|
Description: B2M (Beta-2-Microglobulin) has been genetically removed by CRISPR/Cas9 genome editing from NFAT Luciferase Reporter Jurkat cells. Expression of the firefly luciferase gene is driven by NFAT response elements located upstream of the minimal TATA promoter. Activation of the NFAT signaling pathway in these cells can be monitored by measuring luciferase activity. |
|||
B2M/CIITA Double Knockout THP-1 Cell Line |
|||
| 78391 | BPS Bioscience | 2 vials | EUR 9500 |
|
Description: Both B2M (Beta-2-Microglobulin) and CIITA (Class II Transactivator) have been genetically removed from THP-1 cells using CRISPR/Cas9 genome editing. |
|||
TCR Knockout NFAT-Luciferase Reporter Jurkat Cell Line |
|||
| 78556 | BPS Bioscience | 2 vials | EUR 12205 |
|
Description: This cell line is a knockout of TCR (T Cell Receptor). The TRAC (T-Cell Receptor Alpha Constant) and TRBC1 (T-Cell Receptor Beta Constant 1) domains of the TCRα/β chains were genetically removed by CRISPR/Cas9 genome editing from recombinant Jurkat cells stably expressing the firefly luciferase gene under the control of NFAT response elements.This cell line has been functionally validated and does not respond to anti-CD3 agonist antibodies, as opposed to parental NFAT-Luciferase Reporter Jurkat cells (BPS Bioscience #60621). |
|||
HepG2 Cell Lysate (Human hepatoma cell line) |
|||
| LF-R0017 | Abfrontier | 200 ul | EUR 103.2 |
|
Description: HepG2 (Human hepatoma cell line) Whole Cell Lysate |
|||
pGreenFire1-LXRE in SREBP1c (HepG2 cell line) |
|||
| TR100A-P | SBI | >2 x 10^6 cells | EUR 3915.6 |
pGreenFire1-LXRE in Cyp7A1(HepG2 cell line) |
|||
| TR105A-P | SBI | >2 x 10^6 cells | EUR 3915.6 |
pGreenFire1-LXRE in ABCA1(HepG2 cell line) |
|||
| TR106A-P | SBI | >2 x 10^6 cells | EUR 3915.6 |
pGreenFire1-LXRE in ABCG1(HepG2 cell line) |
|||
| TR107A-P | SBI | >2 x 10^6 cells | EUR 3915.6 |
pGreenFire1-LXRE in ApoE(HepG2 cell line) |
|||
| TR108A-P | SBI | >2 x 10^6 cells | EUR 3915.6 |
pGreenFire1-LXRE in CETP(HepG2 cell line) |
|||
| TR109A-P | SBI | >2 x 10^6 cells | EUR 3915.6 |
TCR/B2M Knockout NFAT Luciferase Reporter Jurkat Cell Line |
|||
| 78557 | BPS Bioscience | 2 vials | EUR 16695 |
|
Description: This cell line is a double knockout of TCR (T Cell Receptor) and B2M (Beta-2-Microglobulin). First, the TRAC (T-Cell Receptor Alpha Constant) and the TRBC1 (T-Cell Receptor Beta Constant 1) domains of the TCRα/β chains were genetically removed by CRISPR/Cas9 genome editing from NFAT Luciferase Reporter Jurkat cells to generate the TCR Knockout NFAT Luciferase Reporter Jurkat cell Line (BPS Bioscience #78556). These TCR knockout cells were used to generate a new cell line in which B2M was also genetically removed by CRISPR/Cas9 genome editing. _x000D_Expression of the firefly luciferase gene is driven by NFAT response elements located upstream of the minimal TATA promoter. Activation of the NFAT signaling pathway in these cells can be monitored by measuring luciferase activity. |
|||
APOA1 sgRNA CRISPR Lentivector set (Human) |
|||
| K0104701 | ABM | 3 x 1.0 ug | EUR 406.8 |
Apoa1 sgRNA CRISPR Lentivector set (Mouse) |
|||
| K4650301 | ABM | 3 x 1.0 ug | EUR 406.8 |
Apoa1 sgRNA CRISPR Lentivector set (Rat) |
|||
| K6843901 | ABM | 3 x 1.0 ug | EUR 406.8 |
APOA1 Blocking Peptide |
|||
| DF6264-BP | Affbiotech | 1mg | EUR 234 |
APOA1 Conjugated Antibody |
|||
| C35570 | SAB | 100ul | EUR 476.4 |